Recent digital health funding highlights strong investor demand for AI-driven care solutions. Investments in companies like Cohere Health reflect the same momentum behind Carta Healthcare’s AI-powered clinical data abstraction, underscoring growing confidence in technology that improves efficiency, quality, and outcomes.
Becker’s reports UPMC Enterprises led an $18.25M Series B1 investment in Carta Healthcare, backing its AI-powered clinical data abstraction platform. The funding accelerates growth and expands use of Carta’s AI tools that streamline data abstraction and analytics for health systems.
Carta Healthcare secured $18.25 M in Series B1 funding led by UPMC Enterprises and other strategic health system investors to expand its AI-powered clinical data abstraction and analytics platform, accelerate growth especially in life sciences, and scale solutions that improve data insights and care delivery.
Carta Healthcare secured $18.25M in Series B1 funding led by UPMC Enterprises with strategic health system investors to expand its AI-powered clinical data abstraction and analytics platform, accelerate growth especially in life sciences, and streamline data insights for care and research.
Investment led by UPMC Enterprises, with participation from MemorialCare Innovation Fund, Rex Health Ventures, Tampa General Hospital Ventures, Memorial Hermann Health System, Frist Cressey Ventures, Storm Ventures, Paramark Ventures, CU Healthcare Innovation Fund, and Mass General Brigham Ventures
The article stresses that better data sharing and collaboration speeds bench-to-bedside discoveries by streamlining clinical trial recruitment and data management using AI. Carta Healthcare’s AI clinical data platform helps accelerate research, extract real-world insights, and match patients to trials, supporting this collaborative translational effort.
At HIMSS25, AI’s practical use in healthcare was a central theme. Vendors, including Carta Healthcare, emphasized real-world AI applications that reduce admin burden, improve workflows, and support value-based care, showing where healthcare tech is moving beyond hype into measurable impact.
The article highlights AI’s role in improving patient outcomes and streamlining healthcare operations, including reducing admin burden and enhancing clinical decision support. Carta Healthcare’s AI clinical data tools fit this trend by improving data accuracy, speeding abstraction, and freeing clinicians for patient care.
Brent Dover, CEO of Carta Healthcare, predicts that in 2024 healthcare AI will grow but must be trained with human expertise due to complex clinical data. He says pairing certified data experts with AI will improve accuracy, build trust, and help address costs and staffing shortages.
Carta Healthcare named Brent Dover as its new CEO, succeeding co-founder Matt Hollingsworth. Dover brings experience from health tech firms including Kalderos and Health Catalyst and will lead strategy, growth, and product innovation.
Carta Healthcare appointed Brent Dover as its new CEO, succeeding co-founder Matt Hollingsworth, who stays on the board. Dover brings extensive health tech leadership experience and will lead growth, product innovation, and strategic expansion.
Carta Healthcare closed a $25M Series B funding round, including new investments from Memorial Hermann Health System and UnityPoint Health, building on an earlier $20M raise. The capital will help scale its clinical data tech that turns complex data into insights to improve patient care and efficiency.
The Becker’s piece shows health systems using generative AI and virtual nursing tools to reduce clinician burden—similar to how Carta Healthcare’s AI‑driven clinical data abstraction platform helps automate documentation and free care teams for higher‑value work.
Carta Healthcare raised $25 M in Series B funding with new investments from Memorial Hermann Health System and UnityPoint Health. The funding will support scaling its AI‑driven clinical data solutions to improve data abstraction, insights, and clinician efficiency across health systems.
The Forbes piece highlights huge administrative waste in healthcare from manual billing, coding, and documentation. Solutions like Carta Healthcare’s AI‑driven clinical data abstraction aim to cut this burden, reduce inefficiency, and free clinicians for more valuable patient care.
In 2022, major systems Mayo Clinic, Mass General Brigham, and Cedars‑Sinai made venture investments in health tech, including Mass General Brigham backing Carta Healthcare’s $20M Series B clinical data platform, showing how health systems are funding digital solutions to improve care and efficiency.
Stay informed with the latest updates and expert insights. Explore breaking news and industry trends all in one place. Contact us for more!
2443 Fillmore St #380-17156 San Francisco, CA 94115
